carbacephems (Lilly)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Namecarbacephems (Lilly)
Drug Alias NameLY-266514LY-246701
ClassificationSmall molecules
Mechanisms of ActionBacterial cell wall synthesis inhibitors
TargetsUpdating
Therapy Area/IndicationsEnterococcus faecium infectionsStreptococcal InfectionsHaemophilus Infections +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEli Lilly And Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEli Lilly And Company
Active IndicationsN/A
Inactive IndicationsEnterococcus faecium infectionsStreptococcal InfectionsHaemophilus Infections +[4] 

Other Information

ATC CodeN/A
Related LinksN/A